Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
Medical Hypotheses|August 25, 2004
DNA methylation inhibitor, procainamide, may decrease the tamoxifen resistance by inducing overexpression of the estrogen receptor beta in breast cancer patientsOzden Altundag, Kadri Altundag, Mehmet Gunduz
Medical Hypotheses|July 9, 2004
Adjuvant targeted therapy with trastuzumab may decrease metastatic capacity in specific group of oropharyngeal cancer patients: downregulation of E-cadherin-catenin complex by cooperative effect of erbB-2 and human papillomavirus type 16 E6/E7 protooncogenesOzden Altundag, Kadri Altundag, Paolo Morandi, et al.
Medical Hypotheses|October 19, 2004
Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifenKadri Altundag, Ozden Altundag, Mehmet Gunduz, et al.
Breast Care (Basel, Switzerland)|June 25, 2026
Gender Disparities in Response to Neoadjuvant Therapy for Early-Stage Breast Cancer: A Propensity Score-Matched Analysis of the SEER DatabaseRashad Ismayilov, Arzu Oguz, Zafer Akcali, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 13, 2016
Response rates of taxane rechallenge in metastatic breast cancer patients previously treated with adjuvant taxanesNadire Kucukoztas, Arzu Oguz, Samed Rahatli, et al.
Medical Hypotheses|June 15, 2004
Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant micrometastatic breast cancer cellsKadri Altundag, Ozden Altundag, Emin Tamer Elkiran, et al.
Medical Hypotheses|October 27, 2004
Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasisOzden Altundag, Kadri Altundag, Yavuz Selim Silay, et al.
Medical Hypotheses|April 13, 2005
Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patientsKadri Altundag, Yavuz S Silay, Ozden Altundag, et al.
Medical Hypotheses|December 21, 2004
SRL172 (killed Mycobacterium vaccae) may augment the efficacy of trastuzumab in metastatic breast cancer patientsKadri Altundag, Ali-Seyed Mohamed, Ozden Altundag, et al.
Medical Oncology (Northwood, London, England)|October 1, 2004
Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapyKadri Altundag, Sercan Aksoy, Ibrahim Gullu, et al.
Pageof 19